154 related articles for article (PubMed ID: 1397206)
1. In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.
Sekhon AS; Padhye AA; Garg AK
Eur J Epidemiol; 1992 May; 8(3):427-32. PubMed ID: 1397206
[TBL] [Abstract][Full Text] [Related]
2. In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine.
Boon-Long J; Mekha N; Poonwan N; Kusum M; Mikami Y; Yazawa K; Konyama K
Mycoses; 1996; 39(11-12):453-6. PubMed ID: 9145003
[TBL] [Abstract][Full Text] [Related]
3. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.
Supparatpinyo K; Nelson KE; Merz WG; Breslin BJ; Cooper CR; Kamwan C; Sirisanthana T
Antimicrob Agents Chemother; 1993 Nov; 37(11):2407-11. PubMed ID: 8285625
[TBL] [Abstract][Full Text] [Related]
4. In vitro interactions of micafungin with amphotericin B, itraconazole or fluconazole against the pathogenic phase of Penicillium marneffei.
Cao C; Liu W; Li R; Wan Z; Qiao J
J Antimicrob Chemother; 2009 Feb; 63(2):340-2. PubMed ID: 19054803
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.
Sar B; Boy S; Keo C; Ngeth CC; Prak N; Vann M; Monchy D; Sarthou JL
J Clin Microbiol; 2006 Nov; 44(11):4208-10. PubMed ID: 16971649
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.
Sekhon AS; Garg AK; Padhye AA; Hamir Z
Eur J Epidemiol; 1993 Sep; 9(5):553-8. PubMed ID: 8307142
[TBL] [Abstract][Full Text] [Related]
7. In vitro sensitivity of medically significant Fusarium species to various antimycotics.
Sekhon AS; Padhye AA; Garg AK; Ahmad H; Moledina N
Chemotherapy; 1994; 40(4):239-44. PubMed ID: 8082411
[TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal drug susceptibilities of Penicillium marneffei from China.
Liu D; Liang L; Chen J
J Infect Chemother; 2013 Aug; 19(4):776-8. PubMed ID: 23104584
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the Sterol Biosynthetic Pathway of Pythium insidiosum and Related Oomycetes Contributes to Antifungal Drug Resistance.
Lerksuthirat T; Sangcakul A; Lohnoo T; Yingyong W; Rujirawat T; Krajaejun T
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115356
[TBL] [Abstract][Full Text] [Related]
10. In Vitro activity of terbinafine combined with caspofungin and azoles against Pythium insidiosum.
Cavalheiro AS; Maboni G; de Azevedo MI; Argenta JS; Pereira DI; Spader TB; Alves SH; Santurio JM
Antimicrob Agents Chemother; 2009 May; 53(5):2136-8. PubMed ID: 19289531
[TBL] [Abstract][Full Text] [Related]
11. Penicillium marneffei: types and drug susceptibility.
Imwidthaya P; Thipsuvan K; Chaiprasert A; Danchaivijitra S; Sutthent R; Jearanaisilavong J
Mycopathologia; 2001; 149(3):109-15. PubMed ID: 11307592
[TBL] [Abstract][Full Text] [Related]
12.
Worasilchai N; Chindamporn A; Plongla R; Torvorapanit P; Manothummetha K; Chuleerarux N; Permpalung N
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015039
[TBL] [Abstract][Full Text] [Related]
13. In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum.
Jesus FP; Ferreiro L; Loreto ÉS; Pilotto MB; Ludwig A; Bizzi K; Tondolo JS; Zanette RA; Alves SH; Santurio JM
Antimicrob Agents Chemother; 2014 Sep; 58(9):5621-5. PubMed ID: 25001300
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of carvacrol and thymol combined with antifungals or antibacterials against Pythium insidiosum.
Jesus FP; Ferreiro L; Bizzi KS; Loreto ÉS; Pilotto MB; Ludwig A; Alves SH; Zanette RA; Santurio JM
J Mycol Med; 2015 Jun; 25(2):e89-93. PubMed ID: 25639921
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of amphotericin B, hamycin and their novel water-soluble compounds against pathogenic yeasts.
Sekhon AS; Padhye AA; Garg AK; Hamir Z
Chemotherapy; 1992; 38(5):297-302. PubMed ID: 1286573
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of antifungals in combination with essential oils against the oomycete Pythium insidiosum.
Valente JS; Fonseca AO; Denardi LB; Dal Ben VS; Maia Filho FS; Zambrano CG; Braga CQ; Alves SH; Botton SA; Brayer Pereira DI
J Appl Microbiol; 2016 Oct; 121(4):998-1003. PubMed ID: 27417677
[TBL] [Abstract][Full Text] [Related]
17. In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei.
Mo D; Li X; Wei L; Sun C; Liang H; Cao C
Mycopathologia; 2014 Oct; 178(3-4):217-20. PubMed ID: 25052248
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Martín E; Parras P; Lozano MC
Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
[TBL] [Abstract][Full Text] [Related]
19. Candida glabrata: in vitro susceptibility of 84 isolates to eight antifungal agents.
Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A
Chemotherapy; 1996; 42(2):107-11. PubMed ID: 8697885
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of zoospores and hyphae of Pythium insidiosum to antifungals.
Fonseca AO; Pereira DI; Maia Filho FS; Osório LG; Maroneze BP; Valente JS; Pötter L; Meireles MC
J Antimicrob Chemother; 2014 Jun; 69(6):1564-7. PubMed ID: 24521855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
